While SEER is an invaluable resource, it does have some limitations:
It covers only about 34.6% of the U.S. population, which may not represent the entire country. Data on cancer recurrence and progression are limited. There may be delays in data reporting, affecting the timeliness of the information.
Despite these limitations, SEER remains one of the most reliable sources of cancer data globally.
